Probiodrug AG announced that on September 30, 2014, the Supervisory Board of the company appointed Dr. Inge Lues as member of the Management Board as Chief Development Officer effective November 1, 2014. Dr. Lues joined Probiodrug as R&D advisor in 2008 and has acted as Chief Development Officer since 2013. As a member of the Management Board she will be responsible for all research and development activities of Probiodrug.

From 2002 until early 2007, Dr. Lues was Head of Global Drug Discovery and Non-Clinical Development Pharma at Merck KGaA and was a member of the Pharma Board.